Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study

Dermatol Ther (Heidelb). 2026 Feb;16(2):701-707. doi: 10.1007/s13555-026-01653-w. Epub 2026 Jan 23.
No abstract available

Publication types

  • Letter